Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;28(8):1332-1344.
doi: 10.1002/lt.26443. Epub 2022 Apr 25.

Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation

Lydia Sastre  1   2 , Raquel García  1 , Clara Viñals  3 , Antonio J Amor  3 , Gema Yago  3 , Alicia Hervás  1 , Lorena Sánchez  3 , Joan Trabal  3 , Judit Molero  3 , Laia Escudé  1 , Giulia Pagano  1 , Miquel Blasco  4 , Rosa Gilabert  5 , Pablo Ruiz  1   6   7 , Jordi Colmenero  1   6   7   8 , Miquel Navasa  1   6   7   8 , Emilio Ortega  3   6   9 , Gonzalo Crespo  1   6   7   8
Affiliations

Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation

Lydia Sastre et al. Liver Transpl. 2022 Aug.

Abstract

Although liver transplantation (LT) recipients are at high cardiovascular risk (CVR), the management of CVR factors (CVRF) after LT is far from optimal and needs to be improved. For this reason, we developed a multidisciplinary protocol to standardize the identification, risk stratification, management, and targets of therapy of CVRF during the first post-LT year. The grade of identification and control of CVRF 12 months after LT in the postintervention cohort (LT January 2018-January 2020, n = 150) were compared with a control cohort who underwent LT between July 2015 and December 2016 (n = 100). Before LT, the prevalence of metabolic-associated fatty liver disease as the indication of LT and the presence of obesity were significantly higher in the postintervention cohort, whereas the prevalence of other CVRF and renal dysfunction tended to be higher. Cyclosporine A was used less frequently in the postintervention cohort, whereas everolimus tended to increase. At 12 months after LT, the proportion of patients with measured blood pressure (88% vs. 56%), glycosilated hemoglobin (HbA1c; 96% vs. 72%), and high-density lipoprotein/low-density lipoprotein cholesterol (67% vs. 33%) was higher in the postintervention than in the control cohort (all p < 0.001). Blood pressure (64% vs. 36%, p = 0.02) and HbA1c (85% vs. 70%, p = 0.1) were within target in more individuals with hypertension and diabetes mellitus, respectively, in the postintervention cohort. Median total cholesterol levels were lower in the postintervention (184 mg/dl; interquartile range [IQR], 160-210 mg/dl) than in the control cohort (212 mg/dl; IQR, 186-240 mg/dl; p = 0.02). At 2 years after LT, the incidence of cardiovascular events was 14% in the control cohort and 6% in the postintervention cohort (p = 0.063). In conclusion, a multidisciplinary, multiprofessional strategy can achieve a higher grade of assessment and management of post-LT CVR despite a worsening metabolic profile of LT recipients.

PubMed Disclaimer

Comment in

References

    1. Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol. 2019;70:745–58.
    1. Crespo G, Trota N, Londoño M‐C, Mauro E, Baliellas C, Castells L, et al. The efficacy of direct anti‐HCV drugs improves early post‐liver transplant survival and induces significant changes in waiting list composition. J Hepatol. 2018;69:11–7.
    1. Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19:580–9.e5.
    1. Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013. JAMA Intern Med. 2014;174:1407–9.
    1. VanWagner LB, Lapin B, Levitsky J, Wilkins JT, Abecassis MM, Skaro AI, et al. High early cardiovascular mortality after liver transplantation. Liver Transpl. 2014;20:1306–16.

Publication types